The global Artificial Intelligence (AI) in Genomics Market is estimated to be valued at US$ 1.15 Bn in 2022
Artificial Intelligence (AI) in Genomics Market |
The global Artificial Intelligence (AI) in Genomics Market is estimated to be valued at US$ 1.15 Bn in 2022 and is expected to exhibit a CAGR of 50.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Artificial Intelligence in genomics helps in interpretation of genetic data,
clinical diagnostics, and drug discovery. It utilizes machine learning
algorithms to analyze DNA sequencing data and medical records for detecting
diseases and risk factors at an early stage. AI draws meaningful conclusions
and insights from large genomic datasets, discovers new biomarkers, and
predicts drug response.
Market key trends:
One of the key trends in the AI in genomics market is the development of
cloud-based genomics software. Cloud genomics software utilizes advanced AI and
machine learning algorithms to analyze genomic and other biological data in the
cloud. It allows researchers and healthcare providers to securely access
genomic tools, computing resources, and datasets from anywhere through an
internet connection. Cloud genomics software minimizes infrastructure costs
while maximizing collaboration and data accessibility for discovery and
translational research.
Segment Analysis
The global AI in genomics market is segmented into offering, technology,
application, end-use, and region. Based on offering, the services segment
dominated the market in 2022 and is expected to continue its dominance during
the forecast period. This is majorly attributed to the increasing demand for
AI-based cloud-based services for genomics applications among pharmaceutical
and biotechnology companies. By technology, the machine learning segment
accounted for the largest share in 2022 due to wide deployment of machine
learning techniques such as deep learning and reinforcement learning in
precision medicine applications. The clinical & healthcare segment captured
a major share under application in 2022 owing to rising adoption of AI for
precision medicine and drug discovery.
Key Takeaways
The global
Artificial Intelligence (AI) in Genomics Market is expected to witness
high growth, exhibiting a CAGR of 50.1% over the forecast period 2023 to 2030,
due to increasing focus on precision medicine and drug discovery.
Regional analysis - The US dominated the global market in 2022 and is anticipated
to maintain its dominance during the forecast period. This is attributed to
conducive government initiatives to promote adoption of AI technology in the
healthcare sector. Asia Pacific is estimated to showcase the fastest growth
through 2030 driven by rising healthcare expenditure, growing geriatric
population, and increasing patient pool in countries like China and India.
Key players - Key players operating in the AI in genomics market are Fabric
Genomics, International Business Machines, MICROSOFT, NVIDIA, AI Therapeutics,
Ares Genetics, Benevolent AI, Deep Genomics, DIPLOID and among others. IBM
captured the largest market share in 2022 owing to its strong foothold and wide
portfolio of AI solutions for genomics.
Read More:
Comments
Post a Comment